RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kane Biotech Stock

Kane Biotech ROCE 2024

Kane Biotech ROCE

0.32

Ticker

KNE.V

ISIN

CA4838092084

In 2024, Kane Biotech's return on capital employed (ROCE) was 0.32, a -38.34% increase from the 0.52 ROCE in the previous year.

Kane Biotech Aktienanalyse

What does Kane Biotech do?

Kane Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Kane Biotech's Return on Capital Employed (ROCE)

Kane Biotech's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Kane Biotech's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Kane Biotech's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Kane Biotech’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Kane Biotech stock

What is the ROCE (Return on Capital Employed) of Kane Biotech this year?

The ROCE of Kane Biotech is 0.32 undefined this year.

How has the ROCE (Return on Capital Employed) of Kane Biotech developed compared to the previous year?

The ROCE of Kane Biotech has increased by -38.34% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Kane Biotech?

A high Return on Capital Employed (ROCE) indicates that Kane Biotech has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Kane Biotech?

A low ROCE (Return on Capital Employed) can indicate that Kane Biotech has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Kane Biotech impact the company?

An increase in the ROCE of Kane Biotech can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Kane Biotech affect the company?

A decrease in ROCE of Kane Biotech can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Kane Biotech?

Some factors that can affect Kane Biotech's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Kane Biotech so important for investors?

The ROCE of Kane Biotech is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Kane Biotech take to improve the ROCE?

To improve the ROCE, Kane Biotech can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Kane Biotech pay?

Over the past 12 months, Kane Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Kane Biotech is expected to pay a dividend of 0 CAD.

What is the dividend yield of Kane Biotech?

The current dividend yield of Kane Biotech is .

When does Kane Biotech pay dividends?

Kane Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Kane Biotech?

Kane Biotech paid dividends every year for the past 0 years.

What is the dividend of Kane Biotech?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Kane Biotech located?

Kane Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kane Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kane Biotech from 9/29/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Kane Biotech pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Kane Biotech in the year 2023?

In the year 2023, Kane Biotech distributed 0 CAD as dividends.

In which currency does Kane Biotech pay out the dividend?

The dividends of Kane Biotech are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kane Biotech

Our stock analysis for Kane Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kane Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.